|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 200.05 USD | +0.05% |
|
+2.41% | +13.67% |
| 06-08 | Needham Upgrades Biogen to Buy From Hold, Price Target is $255 | MT |
| 06-04 | Biogen Receives FDA Breakthrough Therapy Designation for Salanersen for Spinal Muscular Atrophy | CI |
| Market Cap | 29.53B 25.51B 23.51B 22B 41.24B 2,807B 41.87B 278B 108B 1,366B 111B 108B 4,731B | P/E Ratio 2026 * |
32.3x | P/E Ratio 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 35.13B 30.34B 27.96B 26.17B 49.04B 3,339B 49.8B 330B 129B 1,625B 132B 129B 5,627B | EV / Sales 2026 * |
3.5x | EV / Sales 2027 * | 3.2x |
| Free-Float |
85.97% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | +0.05% | ||
| 1 week | +2.41% | ||
| Current month | +2.07% | ||
| 1 month | +0.35% | ||
| 3 months | +8.19% | ||
| 6 months | +14.91% | ||
| Current year | +13.67% |
| 1 week | 192.18 |  | 203.45 |
| 1 month | 184.9 | | 205 |
| Current year | 160.36 | | 205.97 |
| 1 year | 121.05 | | 205.97 |
| 3 years | 110.04 | | 306.52 |
| 5 years | 110.04 | | 410.4 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 13/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 28/02/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 22/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 31/12/2009 |
William Hawkins
BRD | Director/Board Member | 72 | 18/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-08 | Free | Director | 1,505 | 0.0010% | ||
| 06-08 | Free | Director | 1,505 | 0.0010% | ||
| 06-08 | Free | Director | 1,505 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.05% | +2.41% | +51.20% | -36.17% | 29.53B | |
| +0.11% | -3.67% | +17.30% | -18.82% | 62.28B | |
| +1.44% | +5.33% | +68.08% | +223.49% | 60.59B | |
| +0.70% | +29.50% | +29.50% | +29.50% | 39.55B | |
| +0.26% | +9.80% | -55.40% | -64.79% | 36.8B | |
| +0.65% | +6.01% | +56.79% | +74.77% | 21.68B | |
| +0.54% | +5.21% | +82.49% | -59.59% | 19.8B | |
| +4.80% | -0.20% | -5.33% | +112.95% | 16.96B | |
| +0.18% | -1.66% | +49.80% | +101.47% | 16.16B | |
| +0.55% | +9.84% | +140.16% | +240.95% | 13.13B | |
| Average | +0.93% | +3.78% | +43.46% | +60.38% | 31.65B | |
| Weighted average by Cap. | +0.79% | +3.27% | +35.59% | +54.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.03B 8.66B 7.98B 7.47B 14B 953B 14.21B 94.22B 36.74B 464B 37.63B 36.83B 1,606B | 10.36B 8.95B 8.25B 7.72B 14.46B 985B 14.69B 97.36B 37.96B 479B 38.88B 38.05B 1,660B |
| Net income | 1.18B 1.02B 937M 877M 1.64B 112B 1.67B 11.06B 4.31B 54.46B 4.42B 4.32B 189B | 1.97B 1.7B 1.57B 1.47B 2.75B 187B 2.79B 18.5B 7.21B 91.08B 7.39B 7.23B 315B |
| Net Debt | 5.59B 4.83B 4.45B 4.17B 7.81B 532B 7.93B 52.55B 20.49B 259B 20.99B 20.54B 896B | 3.62B 3.12B 2.88B 2.69B 5.05B 344B 5.13B 33.98B 13.25B 167B 13.57B 13.28B 579B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 200.05 $ | +0.05% | 837,294 |
| 11/06/26 | 199.96 $ | +2.94% | 914,781 |
| 10/06/26 | 194.24 $ | -2.44% | 1,071,228 |
| 09/06/26 | 199.10 $ | +3.36% | 934,191 |
| 08/06/26 | 192.62 $ | -1.39% | 1,162,350 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition